MeiraGTx Holdings (MGTX) Total Liabilities (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Total Liabilities of $250.2 million for Q4 2025, up 8.78% on a QoQ basis from $230.0 million in Q3 2025, and up 23.92% year-over-year from $201.9 million in Q4 2024.
MeiraGTx Holdings (MGTX) Total Liabilities (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Total Liabilities history runs 9 years deep, the most recent figure standing at $250.2 million for Q4 2025.
- Quarterly Total Liabilities rose 23.92% year-over-year to $250.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $250.2 million (up 23.92% YoY) and the FY2025 annual result came in at $250.2 million, up 23.92% from the prior year.
- Total Liabilities was $250.2 million for Q4 2025 at MeiraGTx Holdings, up from $230.0 million in the prior quarter.
- Across five years, Total Liabilities topped out at $250.2 million in Q4 2025 and bottomed at $110.5 million in Q2 2022.
- A 5-year average of $175.1 million and a median of $187.1 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities declined 8.72% — and 2023, when it soared 69.01%.
- MeiraGTx Holdings' Total Liabilities stood at $134.8 million in 2021, then soared by 48.78% to $200.5 million in 2022, then fell by 5.95% to $188.6 million in 2023, then advanced by 7.08% to $201.9 million in 2024, then grew by 23.92% to $250.2 million in 2025.
- Business Quant data shows MGTX's Total Liabilities at $250.2 million in Q4 2025, $230.0 million in Q3 2025, and $195.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 250.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 250.22 Mn |
| Sep 30, 2025 | 230.03 Mn |
| Jun 30, 2025 | 195.76 Mn |
| Mar 31, 2025 | 190.92 Mn |
| Dec 31, 2024 | 201.92 Mn |
| Sep 30, 2024 | 203.75 Mn |
| Jun 30, 2024 | 186.61 Mn |
| Mar 31, 2024 | 187.50 Mn |
| Dec 31, 2023 | 188.57 Mn |
| Sep 30, 2023 | 175.31 Mn |
| Jun 30, 2023 | 186.74 Mn |
| Mar 31, 2023 | 197.92 Mn |
| Dec 31, 2022 | 200.50 Mn |
| Sep 30, 2022 | 178.74 Mn |
| Jun 30, 2022 | 110.49 Mn |
| Mar 31, 2022 | 126.41 Mn |
| Dec 31, 2021 | 134.76 Mn |
| Sep 30, 2021 | 115.50 Mn |
| Jun 30, 2021 | 121.05 Mn |
| Mar 31, 2021 | 118.88 Mn |